DG
GILD icon

DMC Group’s Gilead Sciences GILD Stock Holding History

DMC Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Sell
12,702
-644
-5% -$90.2K 1.2% 18
2025
Q4 		$1.64M Sell
13,346
-540
-4% -$65.6K 1.09% 21
2025
Q3 		$1.54M Sell
13,886
-91
-0.7% -$10.3K 1.07% 24
2025
Q2 		$1.55M Sell
13,977
-497
-3% -$52.9K 1.2% 21
2025
Q1 		$1.62M Sell
14,474
-39
-0.3% -$4.02K 1.32% 18
2024
Q4 		$1.34M Buy
14,513
+358
+3% +$32.2K 1.09% 25
2024
Q3 		$1.19M Buy
14,155
+807
+6% +$61.6K 0.96% 29
2024
Q2 		$916K Sell
13,348
-1,266
-9% -$84.5K 0.78% 45
2024
Q1 		$1.07M Sell
14,614
-73
-0.5% -$5.61K 0.92% 37
2023
Q4 		$1.19M Sell
14,687
-37
-0.3% -$2.88K 1.13% 25
2023
Q3 		$1.1M Buy
14,724
+673
+5% +$51.8K 1.03% 29
2023
Q2 		$1.08M Buy
14,051
+992
+8% +$79.1K 1.08% 24
2023
Q1 		$1.09M Buy
13,059
+2,712
+26% +$225K 1.1% 24
2022
Q4 		$884K Buy
10,347
+2,083
+25% +$165K 1% 31
2022
Q3 		$515K Buy
8,264
+1,702
+26% +$107K 0.62% 47
2022
Q2 		$407K Buy
6,562
+1,570
+31% +$97.2K 0.48% 62
2022
Q1 		$311K Sell
4,992
-1,821
-27% -$116K 0.35% 79
2021
Q4 		$458K Buy
+6,813
New +$469K 0.4% 75

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

DMC Group's GILD Position: Q1 2026 in Review

DMC Group reduced its Gilead Sciences (GILD) stake by 4.8% in Q1 2026, selling an estimated $90.2K and leaving 12,702 shares worth $1.77M. The position accounts for 1.2% of the portfolio, ranked #18.

DMC Group first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • DMC Group held 12,702 shares of Gilead Sciences worth $1.77M as of Q1 2026.
  • DMC Group sold 644 Gilead Sciences shares in Q1 2026, an estimated $90.2K.
  • Gilead Sciences made up 1.2% of DMC Group's portfolio in Q1 2026, its #18 holding.
  • DMC Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.